| ID | 118987 |
| 著者 |
Okada, M
Sakamoto Hospital
Iwatsuki, N
Sakamoto Hospital
Sakamoto, K
Sakamoto Hospital
Ogawa, T
Sakamoto Hospital
|
| キーワード | Imeglimin (Twymeeg)
Montreal Cognitive Assessment (MoCA)
Voxel-based Specific Regional analysis system for Alzheimer’s disease (VSRAD)
Clock drawing test（CDT)
Mild cognitive impairment (MCI)
Trials of IMeglimin for Efficacy and Safety (TIMES)
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Recent diabetic topic includes imeglimin (Twymeeg) as a novel oral hypoglycemic agent (OHA).
Case Presentation: The patient is 69-year-old female who has been diabetic for years and developed cognitive problem. Result: Her HbA1c increased to 11.1%, and then Twymeeg 2000mg/day was started. She showed clinical improvement as 7.9% in 4 months. She received Montreal Cognitive Assessment (MoCA), Voxel-based Specific Regional analysis system for Alzheimer’s disease (VSRAD) score and clock drawing test (CDT) associated with diagnosis of mild cognitive impairment (MCI). Discussion: MCI may be one of the diabetic complications and the case will be carefully followed-up. |
| 掲載誌名 |
Journal of Aging Science and Gerontology
|
| 出版者 | Pubtexto Publishers
|
| 巻 | 2
|
| 号 | 1
|
| 開始ページ | 104
|
| 発行日 | 2022-07-01
|
| 権利情報 | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
